Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Impact of Darunavir Monotherapy versus Atripla in HIV Patients
ISRCTN11504121Phase 4Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Oct 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of darunavir, ritonavir and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Change in 25-hydroxyvitamin D. Started Oct 2010; status: completed.
02
Drugs
darunavirritonavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN11504121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11504121.